Emcure Pharmaceuticals Ltd (EMCURE) — Capital Reinvestment Ratio
Emcure Pharmaceuticals Ltd (EMCURE) has a Capital Reinvestment Ratio of 0.50x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs2.56 Billion) in capital expenditures (Rs1.29 Billion). See EMCURE net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Emcure Pharmaceuticals Ltd Capital Reinvestment Ratio (2022–2026)
This chart tracks Emcure Pharmaceuticals Ltd's Capital Reinvestment Ratio across 5 annual periods. Check EMCURE total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year Capital Reinvestment Ratio for Emcure Pharmaceuticals Ltd from 2022 to 2026. For live market cap and broader valuation context, see EMCURE market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.42x | Rs8.51 Billion | Rs3.61 Billion | ▼ -11.3% |
| 2025 | 0.48x | Rs8.52 Billion | Rs4.07 Billion | ▲ +70.7% |
| 2024 | 0.28x | Rs10.97 Billion | Rs3.07 Billion | ▼ -48.2% |
| 2023 | 0.54x | Rs7.47 Billion | Rs4.03 Billion | ▲ +4.5% |
| 2022 | 0.52x | Rs7.68 Billion | Rs3.97 Billion | — |